Eric Abadie Resigns as Chair of the CHMP
Eric Abadie resigns as chair of the CHMP Dr Eric Abadie has informed the European Medicines Agency of his intention to resign as chair of the Committee for Medicinal Products for Human Use (CHMP).
Executive Director Guido Rasi has accepted his resignation with immediate effect.
Dr Tomas Salmonson, vice-chair of the CHMP, will lead the Committee in the meantime to ensure continuity of operations.
Telemedicine Considerations When Conducting Decentralized Clinical Trials
January 14th 2025Compliance with state telemedicine requirements is imperative, as not only will most clinical trial sponsors contractually require such compliance, but non-compliance may also subject the practitioner to licensure violations and liability.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
